BOT 2.21% 33.3¢ botanix pharmaceuticals ltd

Ann: Australian Ethics approval for Acne Study, page-16

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,562 Posts.
    lightbulb Created with Sketch. 327
    I think it's in the midst of a protracted battle for control/company share now.

    'Smart' money knows BOT needs $ to progress (Phase 2 for BTX1503 (Acne) is fully funded, Phase 2 for BTX1204 (AD) is not). SP will be pressured to ensure maximum equity for when BOT look for those BTX1204 Phase 2 $.

    Matt, etc need to announce a revenue generating deal for Permatrex or Acne Wash to get some leverage back imo (or perhaps release details of BTX1801 if it's a game changer)

    The current announcements are great (and further confirm the success story that BOT is turning out to be IMO), but whilst we're still needing those $ for BTX1204 phase 2, there'll be that motivation for 'others' to put the pressure on (until they're in at least)..
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
33.3¢
Change
-0.008(2.21%)
Mkt cap ! $613.3M
Open High Low Value Volume
33.5¢ 34.3¢ 32.5¢ $1.106M 3.309M

Buyers (Bids)

No. Vol. Price($)
10 446168 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
33.5¢ 137445 25
View Market Depth
Last trade - 15.52pm 11/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.